MPG.eBooks - Author Search Results

61

Direct observational therapy for the treatment of tuberculosis : review of clinical evidence and guidelines

by Brett, Kendra, Severn, Melissa
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

62

Rapid and simultaneous tuberculosis and antibiotic susceptibility testing for the diagnosis of and rifampicin resistance : a review of diagnostic accuracy

by Banerjee, Srabani, Severn, Melissa
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

63

Trastuzumab combination and monotherapy for HER2 advanced or recurrent uterine or endometrial cancer : a review of clinical effectiveness and cost-effectiveness

by Gray, Casey, Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

64

PET diagnostic imaging with prostate-specific membrane antigen for prostate cancer : a review of clinical utility, cost-effectiveness, diagnostic accuracy, and guidelines

by Edge, Rob, Picheca, Lory
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

65

Preventative foot care for patients with diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Chao, Yi-Sheng, Spry, Carolyn
Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

66

Clinical review report: Emtricitabine/tenofovir alafenamide fumarate (Descovy)

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

67

Nabilone for chronic pain management : a review of clinical effectiveness and guidelines - an update

by McGolrick, Danielle, Frey, Nina
Published 2018

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

68

Clinical review report: Riociguat (Adempas)

Published 2015

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

69

Day surgery versus overnight stay for laparoscopic cholecystectomy and laparoscopic hernia repair : a review of comparative clinical effectiveness and guidelines

by Ho, Chuong, Spry, Carolyn
Published 2017

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

70

Nabilone for non-chemotherapy associated nausea and vomiting and weight loss due to medical conditions : a review of clinical effectiveness and guidelines

by Narain, Tasha, Farrah, Kelly
Published 2017

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

71

Rituximab for the treatment of myasthenia gravis : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Banerjee, Srabani, Adcock, Lorna
Published 2018

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

72

Rituximab maintenance therapy for the management of granulomatosis with polyangiitis or microscopic polyangiitis : a review of clinical effectiveness, cost-effectiveness, and guide...

by Ho, Chuong, Adcock, Lorna
Published 2018

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

73

Withdrawal management and treatment of crystal methamphetamine addiction in pregnancy : a review of clinical effectiveness and guidelines

by Wells, Charlotte, Loshak, Hannah, Dulong, Camille
Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

74

Pharmacoeconomic review report: Sapropterin dihydrochloride (Kuvan)

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

75

Pharmacoeconomic review report: Omalizumab (Xolair)

Published 2017

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

76

Omalizumab (Xolair)

Published 2017

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

77

Interferon-free regimens for genotype 1 chronic hepatitis C : a review of the clinical evidence and cost-effectiveness

Published 2014

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

78

Pharmacoeconomic review report: Budesonide (Jorveza) : (AVIR Pharma Inc.) : indication : for the induction of clinicopathologic remission in adults with eosinophilic esophagitis

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

79

Pharmacoeconomic report: Halobetasol propionate and tazarotene (Duobrii) : (Bausch Health, Canada Inc.) :indica tion: psoriasis, moderate-to-severe plaque

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

80

Clinical review report: Nintedanib (Ofev) (Boehringer Ingelheim Canada Ltd.) : indication: chronic fibrosing interstitial lung diseases

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”